arrow
M

Martina Nebbia

Department of Clinical Science
H指数:11
被引数:371

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sex-Associated Aspects of Referral, Resectability, and Survival in Patients with Colorectal Liver Metastases (CRLM): A Population-Based Single-Center Study of 1207 MDT-Referred Patients

结直肠癌肝转移(CRLM)患者转诊、可切除性和生存率的性别相关方面:一项基于人群的单中心研究,共纳入1207例多学科团队(MDT)转诊患者

2025-11-290
OAAI
Preoperative carbohydrate antigen 19.9 level predicts lymph node metastasis in resectable adenocarcinoma of the head of the pancreas: a further plea for biological resectability criteria
2024-10-012
OAAI
Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndrome
2024-07-010
OAAI
ASO Visual Abstract: Delta Radiomic Features Predict Resection Margin Status and Overall Survival in Neoadjuvant-Treated Pancreatic Cancer Patients
2024-01-190
OA
Delta Radiomic Features Predict Resection Margin Status and Overall Survival in Neoadjuvant-Treated Pancreatic Cancer Patients

Delta影像组学特征可预测新辅助治疗的胰腺癌患者的切缘状态和总生存率

2023-12-275
OAAI
The Role of Adjuvant Therapy in Duodenal Adenocarcinoma and Intestinal Subtype Ampullary Carcinoma After Curative Resection
2023-10-130
PRE
Long-Term Outcomes of Tuberous Sclerosis Complex-Associated Non-functional Pancreatic Neuroendocrine Tumors: Should We Be More Conservative?

结节性硬化症相关的非功能性胰腺神经内分泌肿瘤的长期预后: 我们应该更保守吗?

2023-08-301
OAAI
ERS: A simple scoring system to predict early recurrence after surgical resection for hepatocellular carcinoma
2023-08-1413
OAAI
Minimally Invasive Versus Open Liver Resections for Hepatocellular Carcinoma in Patients With Metabolic Syndrome
2023-03-307
OA
Model to predict major complications following liver resection for HCC in patients with metabolic syndrome

代谢综合征患者肝癌肝切除术后主要并发症的预测模型

2023-01-0312
PRE
Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria
2022-03-097
PRE